VENKY'S (INDIA) LTD.

Venkys (India) Ltd has released its 50th Annual Report for FY 2025-26. The company reported a sales turnover of ₹3,775 crore and a profit before tax of ₹186 crore for the financial year ended March 31, 2026. Despite a challenging year for the poultry industry marked by lower realizations and high raw material costs, Venky's managed a decent financial performance, especially in the latter half of the year. The Poultry & Poultry Products segment underperformed, while the Animal Health Products segment showed improved performance post-modernization and capacity expansion. The Oilseed segment also bounced back with good performance due to increased volume and cost optimization. The company has recommended a dividend of ₹10 per share and is focusing on maximizing returns from recent investments, including an expansion of its SPF eggs division and considering a new layer farm project in the Northern Region. The balance sheet remains robust with comfortable liquidity.

Venkys (India) Ltd has responded to a BSE query regarding unusual volume movements in its stock. The company stated that it has no undisclosed information or impending announcements that could be influencing the price behavior or trading volumes of its scrip. This clarification aims to address market speculation and provide transparency to investors.

Venkys (India) Ltd has announced Friday, September 11, 2026, as the record date to determine shareholders eligible for dividend payment. The dividend, if approved by members, will be distributed to shareholders whose names appear in the company's register or depositories' records by the close of business on this date. The 50th Annual General Meeting, where the dividend approval will be sought, is scheduled for Tuesday, September 29, 2026, to be held via Video Conferencing (VC) / Other Audio Visual Means (OAVM). This announcement is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Venkys (India) Ltd has announced that its 50th Annual General Meeting (AGM) will be held on Tuesday, September 29, 2026, at 10:30 a.m. The meeting will be conducted through Video Conferencing (VC) and Other Audio Visual Means (OAVM). Additionally, the company has set Friday, September 11, 2026, as the record date. This date will determine the eligibility of shareholders to receive any dividend on equity shares, subject to approval at the AGM. Shareholders registered by the close of business on this date, or beneficial owners in electronic form, will be entitled to the dividend.

Venkys (India) Limited announced its financial results for the quarter ended June 30, 2026. The company reported revenues from operations of ₹1,118.38 Cr, with Profit Before Tax at ₹69.27 Cr and Profit After Tax at ₹49.99 Cr. Earnings Per Share (EPS) stood at ₹35.49. The company highlighted strong performance across its three business segments: Poultry & Poultry Products, Animal Health Products, and Oilseed Segment, driven by improved volumes, better realization, product mix, and cost optimization measures, despite higher feed prices in the poultry segment.

Venky's (India) reported standalone Q1 FY27 (quarter ended 30 June 2026) revenue from operations of ₹1,118.4 Cr, up 29.2% YoY from ₹865.8 Cr and up a modest 1.6% QoQ from ₹1,100.5 Cr. Net profit more than tripled YoY to ₹49.99 Cr (from ₹15.83 Cr in Q1 FY26) with basic EPS of ₹35.49 versus ₹11.24 a year ago, though PAT fell ~48% QoQ from the seasonally stronger Q4 FY26 print. This is a standalone-only filing — Venky's does not disclose a consolidated statement, so there is no separate consolidated figure to reconcile against. The YoY improvement was margin-led as well as volume-led: net margin (PAT/total income) expanded to 4.4% from 1.8%, and operating margin (EBITDA excluding other income, over revenue) rose to about 6.2% from 2.7% a year ago — both, however, down sharply from Q4 FY26's seasonal peak (NPM 8.7%, OPM 11.8%), consistent with the seasonal swings management has flagged for this business. By segment, Poultry & Poultry Products swung from a ₹5.7 Cr pre-tax segment loss in Q1 FY26 to a ₹16.3 Cr profit this quarter, with the company citing improved volumes and realization even as feed prices stayed elevated. Oilseed was the standout: segment revenue rose ~66% YoY to ₹527.9 Cr and segment profit rose ~208% YoY to ₹31.0 Cr on higher volumes and cost optimization. Animal Health Products profit grew ~31% YoY to ₹30.3 Cr on better volumes and product mix. Against the prior (Q4 FY26) concall guidance — continued growth led by Animal Health and Oilseed, with poultry expected to be broadly consistent YoY subject to seasonality — the quarter reads as a beat: Oilseed's growth well exceeds the 'maintain or improve' bar management set, Animal Health's profit growth clears the guided double-digit pace, and poultry did better than 'consistent,' turning a year-ago segment loss into a profit. No analyst consensus or brokerage preview for this quarter could be located — Venky's is thinly covered by brokerages — so the print cannot be benchmarked against a street number; vsStreet is recorded as unknown. The filing's own notes attribute the quarter to better volumes/realization in poultry, product-mix gains in Animal Health, and cost optimization in Oilseed, consistent with the reported segment numbers. There were no exceptional items or minority interest in either period, so the YoY PAT growth is not adjustment-distorted — but it does reflect a low base, since Q1 FY26's poultry segment was loss-making on high feed costs, a headwind that has now reversed even though feed costs remain elevated.

Venkys (India) Ltd has announced that its Board of Directors will convene on August 11, 2026. The primary agenda item for this meeting is to consider, approve, and take on record the audited financial results for the first quarter ended June 30, 2026. This announcement is made in compliance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has informed both the Bombay Stock Exchange (BSE Scrip Code: 523261) and the National Stock Exchange of India (NSE Symbol: VENKEYS).

Venky's (India) Limited announced its financial results for the year ended March 31, 2026. Revenues from operations stood at ₹3,727.32 Cr with a Profit Before Tax of ₹185.55 Cr and Profit After Tax of ₹139.25 Cr. EPS stood at ₹98.85. The Board has recommended a dividend of ₹10 (100%) per share. The company reported improved performance across all three segments: Poultry, Animal Health, and Oilseed.

The Board of Directors of Venkys (India) Ltd has recommended a final dividend of ₹10 per equity share (100%) for the financial year ended March 31, 2026. The dividend is subject to the approval of shareholders at the upcoming Annual General Meeting. If approved, the dividend will be paid within the statutory time limit after the AGM. The board meeting commenced at 10:30 AM IST and concluded at 12:30 PM IST.

Venky's (India) Limited announced its audited financial results for the year ended March 31, 2026. The company reported revenue from operations of ₹372.73 crores and a profit after tax of ₹13.92 crores. The Board of Directors has recommended a dividend of ₹10 per equity share (100%) for the year, subject to shareholder approval at the Annual General Meeting. The board meeting, which reviewed and approved the results, commenced at 10:30 AM IST and concluded at 12:30 PM IST on May 14, 2026.